[Niflumic acid in otorhynolaryngologic inflammation in childhood. Controlled study versus feprazone].
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D011298:Feprazone / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007249:Inflammation / Q000188:drug therapy; D008297:Male; D009539:Nicotinic Acids / Q000627:therapeutic use*; D009544:Niflumic Acid / Q000627:therapeutic use*; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*; D010653:Phenylbutazone / Q000031:analogs & derivatives*; D011897:Random Allocation
D009539:Nicotinic Acids; D009544:Niflumic Acid; D011298:Feprazone; D010653:Phenylbutazone
L'acido niflumico nelle flogosi ORL in pediatria. Studio controllato versus feprazone.